Literature DB >> 11950065

Association analysis of nine missense polymorphisms in the coagulation factor V gene with severe preeclampsia in pregnant Japanese women.

Hideki Watanabe1, Hiromi Hamada, Naoki Yamada, Satoshi Sohda, Kimiko Yamakawa-Kobayashi, Hiroyuki Yoshikawa, Tadao Arinami.   

Abstract

The Leiden mutation in the coagulation factor V (F5) gene associated with preeclampsia in Caucasians has not been found in Japanese populations. We examined the association of 20 missense polymorphisms in the F5 gene in 133 pregnant Japanese women with preeclampsia and in 224 unrelated, healthy, pregnant Japanese women. Among nine polymorphisms identified in the subjects, the M385T and R485K polymorphisms were associated with preeclampsia (P = 0.05 and P = 0.02, respectively). Haplotype analysis indicated that the R485K polymorphism is truly associated with preeclampsia, whereas the association of the M385T polymorphism is due to linkage disequilibrium. Taken together with reports that the R485 allele yields poor factor V function in comparison with that of the K485 allele and that the F5 Leiden mutation is associated with preeclampsia in Caucasian populations, the findings of the present study suggest that the F5 gene is associated with preeclampsia in pregnant Japanese women.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950065     DOI: 10.1007/s100380200014

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  2 in total

1.  Establishment of a method of anonymization of DNA samples in genetic research.

Authors:  Kazuo Hara; Kazuhiko Ohe; Takashi Kadowaki; Naoya Kato; Yasushi Imai; Katsushi Tokunaga; Ryozo Nagai; Masao Omata
Journal:  J Hum Genet       Date:  2003-05-15       Impact factor: 3.172

2.  MTHFR and F5 genetic variations have association with preeclampsia in Pakistani patients: a case control study.

Authors:  Feriha Fatima Khidri; Yar Muhammad Waryah; Faiza Kamran Ali; Hina Shaikh; Ikram Din Ujjan; Ali Muhammad Waryah
Journal:  BMC Med Genet       Date:  2019-10-23       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.